Reducing Staphylococcus aureus resistance to lysostaphin using CRISPR‐dCas9

Synthetic biology of modular endolysins

(2018) Hans Gerstmans et al.   BIOTECHNOLOGY ADVANCES

Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics

(2018) Craig R. MacNair et al.   Nature Communications

Flexible Peptide Linkers Enhance the Antimicrobial Activity of Surface-Immobilized Bacteriolytic Enzymes

(2018) Xia Wu et al.   ACS Applied Materials & Interfaces

Biocatalytic Nanocomposites for Combating Bacterial Pathogens

(2017) Xia Wu et al.   Annual Review of Chemical and Biomolecular Engineering

Dissemination of antibiotic resistance genes from antibiotic producers to pathogens

(2017) Xinglin Jiang et al.   Nature Communications

Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance

(2017) Jonathan M. Stokes et al.   Nature Microbiology

Wall teichoic acids mediate increased virulence in Staphylococcus aureus

(2017) Stefanie Wanner et al.   Nature Microbiology

Bacteriophage endolysins: applications for food safety

(2016) Mathias Schmelcher et al.   CURRENT OPINION IN BIOTECHNOLOGY

Wall Teichoic Acids Are Involved in the Medium-Induced Loss of Function of the Autolysin CD11 against Clostridium difficile

(2016) Xia Wu et al.   Scientific Reports

Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity

(2015) Daniel C. Osipovitch et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

EC300: a phage-based, bacteriolysin-like protein with enhanced antibacterial activity against Enterococcus faecalis

(2015) Daniela Proença et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Growth inhibition of Mycobacterium smegmatis by mycobacteriophage-derived enzymes

(2014) Navdeep Grover et al.   ENZYME AND MICROBIAL TECHNOLOGY

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials

(2014) David Bikard et al.   NATURE BIOTECHNOLOGY

Wall Teichoic Acids of Gram-Positive Bacteria

(2013) Stephanie Brown et al.   Annual Review of Microbiology

Discovery of Wall Teichoic Acid Inhibitors as Potential Anti-MRSA β-Lactam Combination Agents

(2013) Hao Wang et al.   CHEMISTRY & BIOLOGY

Teichoic acid biosynthesis as an antibiotic target

(2013) Lincoln W Pasquina et al.   CURRENT OPINION IN MICROBIOLOGY

Taking aim at wall teichoic acid synthesis: new biology and new leads for antibiotics

(2013) Edward WC Sewell et al.   JOURNAL OF ANTIBIOTICS

Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus–Induced Murine Bacteremia

(2013) Raymond Schuch et al.   JOURNAL OF INFECTIOUS DISEASES

Resistance in tuberculosis: what do we know and where can we go?

(2013) Keith D. Green et al.   Frontiers in Microbiology

Phage Endolysins with Broad Antimicrobial Activity Against Enterococcus faecalis Clinical Strains

(2012) Daniela Proença et al.   Microbial Drug Resistance

The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile

(2011) Shonna M. McBride et al.   MICROBIOLOGY-SGM

Synthetic Lethal Compound Combinations Reveal a Fundamental Connection between Wall Teichoic Acid and Peptidoglycan Biosyntheses inStaphylococcus aureus

(2010) Jennifer Campbell et al.   ACS Chemical Biology

Multidrug Resistance in Bacteria

(2009) Hiroshi Nikaido   Annual Review of Biochemistry

Wall Teichoic Acid Function, Biosynthesis, and Inhibition

(2009) Jonathan G. Swoboda et al.   CHEMBIOCHEM

A Eukaryotic-like Ser/Thr Kinase Signals Bacteria to Exit Dormancy in Response to Peptidoglycan Fragments

(2008) Ishita M. Shah et al.   CELL